Bard Associates Inc. Decreases Holdings in The Joint Corp. (NASDAQ:JYNT)

Bard Associates Inc. trimmed its stake in shares of The Joint Corp. (NASDAQ:JYNT) by 1.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 84,050 shares of the company’s stock after selling 1,384 shares during the quarter. Bard Associates Inc. owned 0.56% of Joint worth $962,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its stake in shares of Joint by 5.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock valued at $229,000 after acquiring an additional 837 shares during the last quarter. O Brien Greene & Co. Inc lifted its holdings in shares of Joint by 0.9% during the 2nd quarter. O Brien Greene & Co. Inc now owns 115,620 shares of the company’s stock valued at $1,626,000 after buying an additional 1,000 shares during the period. Avondale Wealth Management grew its position in Joint by 15.8% during the second quarter. Avondale Wealth Management now owns 22,000 shares of the company’s stock valued at $309,000 after buying an additional 3,000 shares during the period. Russell Investments Group Ltd. raised its stake in shares of Joint by 8.9% in the first quarter. Russell Investments Group Ltd. now owns 90,147 shares of the company’s stock worth $1,177,000 after buying an additional 7,375 shares during the period. Finally, Verus Capital Partners LLC lifted its stake in shares of Joint by 5.9% during the 3rd quarter. Verus Capital Partners LLC now owns 132,955 shares of the company’s stock valued at $1,521,000 after buying an additional 7,440 shares in the last quarter. 76.88% of the stock is currently owned by hedge funds and other institutional investors.

Joint Stock Down 2.9 %

Shares of JYNT opened at $11.22 on Friday. The Joint Corp. has a 52-week low of $8.29 and a 52-week high of $17.82. The stock has a 50 day moving average price of $11.31 and a 200 day moving average price of $12.96.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on JYNT. Roth Mkm lowered their price target on Joint from $16.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, November 8th. StockNews.com raised Joint from a “hold” rating to a “buy” rating in a report on Friday.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.